Luc Vandenberghe, PhD
President at Lyora Therapeutics.
- Belmont, MA
- Form D signer
- Lyora Therapeutics
Raised on Lyora Therapeutics filings
$525K
of $2M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 1
- Last filing
- Mar 11, 2025
Company
Lyora Therapeutics
Biotech · Belmont, MA
Clinical-stage biotechnology company dedicated to developing groundbreaking therapies specifically for chronic rhinosinusitis (CRS), a prevalent…
Clinical-stage biotechnology company dedicated to developing groundbreaking therapies specifically for chronic rhinosinusitis (CRS), a prevalent…
- Investors
- 4
- Founded
- 2024
- Still open
- $1.5M
Lyora Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Mar 11, 2025 | Option to acquire | $525K/ $2M | Form D |
- Option to acquireFiled Mar 11, 2025Form D$525K/ $2M
